133 Molesworth Street
PO Box 5013
Wellington 6140
New Zealand
T+64 4 496 2000
28 March 2023
J Bruning
Email:
[FYI request #22085 email]
Ref:
H2023021708
Tēnā koe J Bruning
Partial transfer of your request for official information Thank you for your request under the Official Information Act 1982 (the Act) to Manatū Hauora
(the Ministry of Health) on 13 March 2023. In part of your request, you asked :
“Please supply urgently, between 27 February 2021 and 9 March 2021 the following
information: [a] All discussions via WhatsApp, Signal, Messenger, private email, Parliamentary or
political party email by officials, including Ministers and the Director General of Health
discussing Pfizer, BioNTech, the post-marketing report, FDA, deaths and adverse events.
Manatū Hauora does not hold any information relating to this part of your request; however, I
have been advised that this information is held by Te Whatu Ora – Health New Zealand. For this
reason, I have decided to transfer this part of your request to Te Whatu Ora under section
14(b)(i) of the Act. You can expect a response from their agency in due course.
The Ministry will respond to the remaining parts of your request.
Under section 28(3) of the Act, you have the right to ask the Ombudsman to review any
decisions made under this request. The Ombudsman may be contacted by email at:
[email address] or by calling 0800 802 602.
Nāku noa, na
Elisabeth Brunt
Group Manager, Government Services Government and Executive Services | Te Pou Whakatere Kāwanatanga
COPY OF OIA REQUEST
“Please supply urgently, between 27 February 2021 and 9 March 2021 the following
information:
[a] All discussions via WhatsApp, Signal, Messenger, private email, Parliamentary or
political party email by officials, including Ministers and the Director General of Health
discussing Pfizer, BioNTech, the post-marketing report, FDA, deaths and adverse events.
[b] All reports, releases, memos, advice discussing and/or reviewing the implications of,
contents, evidence in the post-marketing report supplied as a requirement in the Gazette
conditions, and taking all steps to reasonably consider the harm profile to the population
who were not at risk of hospitalisation or death from COVID-19 (required by Health Act,
Part3A, s.92, Overarching Principles). This includes the risk to pregnant women, young
people and children.
https://scanmail.trustwave.com/?c=15517&d=xPWO5IG0S9IG1QQH39rnTkhgZdcJdfKRS
4ydMCk7zQ&u=https%3a%2f%2fwww%2elegislation%2egovt%2enz%2fact%2fpublic%2f
1956%2f0065%2flatest%2fwhole%2ehtml%23DLM307296
This cohort [group 4], 2 million people, were targeted by the Minister for COVID-19 to be
injected from July 2021. General civil society would be required to be injected to work, to
access services and public facilities. Therefore, it would be expected that a risk-benefit
analyses for these individuals would be undertaken so as to protect public health, as
required by the overarching legislation.
https://scanmail.trustwave.com/?c=15517&d=xPWO5IG0S9IG1QQH39rnTkhgZdcJdfKRS
4HJZSttnA&u=https%3a%2f%2fcovid19%2egovt%2enz%2fnews-and-data%2flatest-
news%2fcovid-19-vaccine-rollout-plan%2f
[c] All discussions via WhatsApp, Signal, Messenger, private email, Parliamentary or
political party email sent by officials, including Ministers and the Director General of Health
planning and discussing the signing of the second agreement.”
Page 2 of 2
